drugset / Trial / NCT00201123

Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs

NCT00201123

RandomizedParallel-groupSingle-blindTreatment

Summary

This study will evaluate the lung's immune response to mycobacterium tuberculosis (Mtb) infection and will modulate that response with interferon-gamma.

Timeline

Start
2005-04
Primary completion
2007-01
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Interferon gamma-1b Protein / enzyme biologic Other